MR编号 | DE/H/0299/003 |
---|
药品名称 | Levocetirizin Saft |
---|
活性成分 | - Levocetirizine dihydrochloride 0.5 mg/ml
|
---|
剂型 | Oral solution |
---|
上市许可持有人 | UCB Pharma GmbH
Alfred-Nobel-Str. 10
40789 Monheim
Germany |
---|
参考成员国 - 产品名称 | Germany (DE) |
---|
互认成员国 - 产品名称 | - Denmark (DK)
- Belgium (BE)
- Netherlands (NL)
Xyzal 0.5 mg/ml drank - Luxembourg (LU)
- United Kingdom (Northern Ireland) (XI)
- Ireland (IE)
- France (FR)
- Spain (ES)
- Portugal (PT)
Xyzal - Italy (IT)
- Greece (GR)
- Norway (NO)
- Finland (FI)
- Poland (PL)
Xyzal - Latvia (LV)
Xyzal 0,5 mg/ml šķīdums iekšķīgai lietošanai - Lithuania (LT)
Xyzal 0,5 mg/ml geriamasis tirpalas - Estonia (EE)
Xyzal - Hungary (HU)
XYZAL 0,5 mg/ml belsőleges oldat - Cyprus (CY)
XYZAL ORAL SOLUTION 0.5MG/ML - Czechia (CZ)
- Slovakia (SK)
Xyzal 5 mg/10 ml perorálny roztok - Slovenia (SI)
- Malta (MT)
XYZAL
|
---|
许可日期 | 2006/05/09 |
---|
最近更新日期 | 2025/01/27 |
---|
药物ATC编码 | |
---|
申请类型 | - TypeLevel1:Known Active Substance
- TypeLevel2:Initial Application
- TypeLevel3:Full Dossier Art 8.3(i) Dir 2001/83/EC
- TypeLevel4:Chemical Substance
- TypeLevel5:Prescription Only
|
---|
附件文件下载 | |
---|
市场状态 | Positive |
---|